Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan + HCT in Obese Hypertensive Patients
NCT00775814Phase 4Completed
- Sponsor
- Takeda
- Start
- Oct 2006
- Primary completion
- Sep 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of candesartan in hypertension (HTN) (2 arms), sponsored by Takeda. Primary endpoint: Change from Baseline in Diastolic Blood Pressure. Started Oct 2006; status: completed.
02
Drugs
candesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00775814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00775814.